P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis
- 1 November 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (5) , 1659-1671
- https://doi.org/10.1046/j.1523-1755.2002.00621.x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Molecular cloning and characterization of rat P2Y4 nucleotide receptorBritish Journal of Pharmacology, 1998
- Cloning of a Human Purinergic P2Y Receptor Coupled to Phospholipase C and Adenylyl CyclasePublished by Elsevier ,1997
- Extraglomerular origin of the mesangial cell after injury. A new role of the juxtaglomerular apparatus.Journal of Clinical Investigation, 1997
- Second messenger cascade specificity and pharmacological selectivity of the human P2Y1‐purinoceptorBritish Journal of Pharmacology, 1996
- Cloning, Expression, and Chromosomal Localization of the Human Uridine Nucleotide Receptor GenePublished by Elsevier ,1995
- Extracellular ATP and UTP activation of phospholipase D is mediated by protein kinase C-ε in rat renal mesangial cellsBritish Journal of Pharmacology, 1993
- Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotidesAmerican Journal of Physiology-Cell Physiology, 1993
- Increased synthesis of extracellular matrix in mesangial proliferative nephritisKidney International, 1991
- Quantitative and qualitative studies of antibody–induced mesangial cell damage in the ratKidney International, 1987
- Extracellular ATP: effects, sources and fateBiochemical Journal, 1986